HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AAD counters Berwick analysis that skin cancer is likely regardless of sunscreen use.

This article was originally published in The Rose Sheet

Executive Summary

AAD COUNTERS CLAIM THAT SKIN CANCER LIKELY REGARDLESS OF SUNSCREEN USE in a March 12 letter from former President Roger Ceilley, MD, to epidemiologist Marianne Berwick, PhD, Memorial Sloan-Kettering Cancer Center. Ceilley's letter responds to a presentation given by Berwick at the American Association for the Advancement of Science annual meeting in which she claimed study data suggest some individuals are "likely to develop skin cancer regardless of the amount of sunlight exposure or protection from sunscreen." In Ceilley's letter, the American Academy of Dermatology maintains "there are no data to support that statement."
Advertisement

Related Content

High SPF Sunscreens Increase Sun Exposure By 25%, Cancer Study Finds
High SPF Sunscreens Increase Sun Exposure By 25%, Cancer Study Finds
Advertisement
UsernamePublicRestriction

Register

RS005250

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel